Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navar

Showing results (611-620 of 711) with videos related to

Pageof 72
Sort By:
JAMA Cardiology|December 10, 2025
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate ReductionPaul M Ridker, Florian M M Baeres, Anders Hveplund, et al.
Journal of the American Heart Association|March 15, 2021
Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-AnalysisSiva H Yedlapati, Safi U Khan, Swapna Talluri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 2012
Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney diseaseKatherine T Mills, Hiroyuki Kobori, Lotuce Lee Hamm, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2016
An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective EndocarditisJoseph A Sivak, Amit N Vora, Ann Marie Navar, et al.
Journal of the American College of Cardiology|April 22, 2026
Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical TrialAlberico L Catapano, Elina Mikhailova, Ann Marie Navar, et al.
Journal of the American Heart Association|February 19, 2025
Associations of a Composite Stress Measurement Tool With Cardiovascular Risk Factors and Outcomes: Findings From the Dallas Heart StudyIjeoma Eleazu, Colby Ayers, Ann Marie Navar, et al.
American Heart Journal|November 7, 2015
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registryAnn Marie Navar, Tracy Y Wang, Anne C Goldberg, et al.
European Journal of Preventive Cardiology|October 1, 2025
Factors Associated with Elevated High-Sensitivity C-Reactive Protein Levels in Individuals with Atherosclerotic Cardiovascular Disease in the US and the UKKausik K Ray, Simon Bertram Reuter, Aysegul Dalbeler, et al.
JAMA Surgery|August 13, 2025
Patient Portal Use Among Admitted Surgical Patients Following the 21st Century Cures ActAndrew P Bain, Ryan Heslin, Lynley Matthews, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Associations of Cumulative Perceived Stress with Cardiovascular Risk Factors and Outcomes: Findings from The Dallas Heart StudyIjeoma Eleazu, Colby Ayers, Ann Marie Navar, et al.
Pageof 72

Showing results (611-620 of 711) with videos related to

Sort By:
Pageof 72
JAMA Cardiology|December 10, 2025
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate ReductionPaul M Ridker, Florian M M Baeres, Anders Hveplund, et al.
Journal of the American Heart Association|March 15, 2021
Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-AnalysisSiva H Yedlapati, Safi U Khan, Swapna Talluri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 2012
Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney diseaseKatherine T Mills, Hiroyuki Kobori, Lotuce Lee Hamm, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2016
An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective EndocarditisJoseph A Sivak, Amit N Vora, Ann Marie Navar, et al.
Journal of the American College of Cardiology|April 22, 2026
Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical TrialAlberico L Catapano, Elina Mikhailova, Ann Marie Navar, et al.
Journal of the American Heart Association|February 19, 2025
Associations of a Composite Stress Measurement Tool With Cardiovascular Risk Factors and Outcomes: Findings From the Dallas Heart StudyIjeoma Eleazu, Colby Ayers, Ann Marie Navar, et al.
American Heart Journal|November 7, 2015
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registryAnn Marie Navar, Tracy Y Wang, Anne C Goldberg, et al.
European Journal of Preventive Cardiology|October 1, 2025
Factors Associated with Elevated High-Sensitivity C-Reactive Protein Levels in Individuals with Atherosclerotic Cardiovascular Disease in the US and the UKKausik K Ray, Simon Bertram Reuter, Aysegul Dalbeler, et al.
JAMA Surgery|August 13, 2025
Patient Portal Use Among Admitted Surgical Patients Following the 21st Century Cures ActAndrew P Bain, Ryan Heslin, Lynley Matthews, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Associations of Cumulative Perceived Stress with Cardiovascular Risk Factors and Outcomes: Findings from The Dallas Heart StudyIjeoma Eleazu, Colby Ayers, Ann Marie Navar, et al.
Pageof 72